<![CDATA[FDA Clears TriNav Advance for Expanded Liver Embolization Access]]>
RegulatoryapprovedTriNav AdvancePositive
AI Analysis
Summary
The FDA cleared TriSalus's TriNav Advance device, which uses SmartValve-based drug delivery technology to improve tumor penetration during liver embolization procedures.
Outcome Details
FDA cleared TriNav Advance device for expanded liver embolization access
Importance:8/10
Sentiment:
0.85
FDA clearancemedical deviceliver embolizationdrug deliverySmartValve technology
Related Companies
Read the original article
Published by Cancer Network on September 25, 2026 12:00 PM